US stock · figures in US dollars · scored on full-year results
Becton Dickinson Becton, Dickinson and Company Common Stock
Becton Dickinson scores 31/100 on fundamentals: in the bottom 4% of 503 scored S&P 500 stocks. Its strongest area is Risk (67/100); its weakest is Price Fairness (0/100). It carries 1 warning flag: Weak Spot.
- Carries a Weak Spot flag
A financially stretched, expensively priced stock, but price fairness needs attention.
Nearby peers
Ranks #57 of 60 in Healthcare by score
One-Minute Summary
Why Becton Dickinson scores 31
A financially stretched, expensively priced stock, but price fairness needs attention.
Business Strength
10Why 10?
Show 3 charts
Net Profit & Equity, with ROE
Revenue & Net Profit, with Net Margin
Sales grew about 16.1% over 4 years: customers keep spending more with this company.
Profit fell about 36.5% from where it was 4 years ago: the boom has cooled off.
Recent Quarters: Revenue & Net Profit (the last 8 quarters, scored)
Sales fell about 8.4% over the last 8 quarters: worth watching why.
The company made a loss in at least one of the last 8 quarters: the bars below zero are losses, not profits.
Financial Safety
33Why 33?
Show 2 charts
Debt vs Equity, with D/E ratio
Borrowings have stayed roughly level: manageable, as long as profits stay healthy.
Short-term assets vs bills, with Current Ratio
Cash & Dividends
38Why 38?
Show 3 charts
Operating vs Free Cash Flow
Cash keeps coming in, though unevenly: fine, but worth keeping an eye on.
Cash vs Total Debt
Dividends per Share, with Yield
Dividends per share have been maintained or raised: management shares the rewards with you.
Price FairnessLowest pillar
0Why 0?
Show chart
Share Price: Weekly Closes (not part of the score)
The share price is up about 44.4% over the past year.
Risk
67Why 67?
Show chart
Revenue vs Inventory, with Inventory % of Revenue
Sector peers
Becton Dickinson (BDX) scores 31/100 (Weak) on Score Your Stock's educational fundamentals model: in the bottom 4% of 503 scored S&P 500 stocks.
Its strongest pillar is Risk (67/100); its weakest is Price Fairness (0/100).
Becton Dickinson ranks #57 of 60 scored Healthcare stocks on Score Your Stock.
Yes. Becton Dickinson (BDX) has a dividend yield of 2%, from dividends with an ex-date in the last 12 months. It pays out 124% of its profit as dividends. Its Cash & Dividends pillar scores 38/100.
From Malaysia, open an account with a broker that offers US shares (many local and app-based brokers do), convert ringgit to US dollars, then buy BDX. US shares trade one share at a time, not in lots of 100. Check the currency conversion fee and US dividend tax (usually 30% withheld for Malaysians) before you buy.
The overall score pools every measure across 5 weighted pillars: Business Strength, Financial Safety, Cash & Dividends, Price Fairness, and Risk. It uses the same rules as our Bursa scores. For banks, Financial Safety checks nonaccrual (impaired) loans, loan loss coverage and the CET1 capital ratio, from the FDIC call report of the group's main bank. Full methodology and the default weights: https://scoreyourstock.com/how. This is an educational tool, not investment advice.
Becton Dickinson (BDX) is a Healthcare company (Medical Instruments & Supplies). On Score Your Stock's fundamentals check, it scores 31/100, rated Weak. Its biggest strength is Risk (67/100); its main watch-out is Price Fairness (0/100). Shares currently cost about 57 years of its current profit to buy (P/E 57.2×). It also pays back about 2.0% of the share price as dividends each year. Full breakdown and daily-updated score: https://scoreyourstock.com/stocks/us/bdx-becton-dickinson
Full Financial History
Every reported figure behind the score, year by year. Download it, or check it against the company's own annual report.
| Financial Year | Revenue | Net Profit | Operating Cash Flow | Free Cash Flow | CapEx | Cash | Total Debt | Short-Term Debt | Equity | Current Assets | Current Liabilities | Total Assets | Total Liabilities | Inventory | Dividends | Return on Equity (ROE) | Net Profit Margin | Debt-to-Equity | Current Ratio | Interest Coverage | Dividend Payout Ratio | Div yield | P/E Ratio | P/B Ratio | PEG Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | US$ 22.5b | US$ 942.0m | US$ 3.3b | US$ 2.5b | US$ -753.0m | US$ 708.0m | US$ 16.8b | US$ 3.3b | US$ 24.4b | US$ 8.1b | US$ 9.4b | US$ 50.7b | US$ 26.3b | US$ 3.3b | US$ 397.6m | 4% | 4% | 0.7× | 0.9× | 4.2× | 124% | - | - | - | - |
| 2025 | US$ 21.8b | US$ 1.7b | US$ 3.4b | US$ 2.7b | US$ -760.0m | US$ 641.0m | US$ 19.2b | US$ 1.6b | US$ 25.4b | US$ 9.3b | US$ 8.3b | US$ 55.3b | US$ 29.9b | US$ 3.9b | US$ 327.0m | 7% | 8% | 0.8× | 1.1× | 4.1× | 71% | 2% | 25.3× | 1.7× | - |
| 2024 | US$ 20.2b | US$ 1.7b | US$ 3.8b | US$ 3.1b | US$ -725.0m | US$ 1.7b | US$ 20.1b | US$ 2.2b | US$ 25.9b | US$ 10.5b | US$ 9.0b | US$ 57.3b | US$ 31.4b | US$ 3.8b | US$ 298.7m | 7% | 8% | 0.8× | 1.2× | 4.8× | 65% | 2% | 30.4× | 2.0× | - |
| 2023 | US$ 19.4b | US$ 1.5b | US$ 3.0b | US$ 2.1b | US$ -874.0m | US$ 1.4b | US$ 15.9b | US$ 1.1b | US$ 25.8b | US$ 8.7b | US$ 6.6b | US$ 52.8b | US$ 27.0b | US$ 3.3b | US$ 286.2m | 6% | 8% | 0.6× | 1.3× | 4.7× | 75% | 2% | 37.4× | 2.2× | 1.9 |